Luigi Portella

3PUBLICATIONS
29CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 28, 2026
CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cells.

Federica Auletta, Caterina Ieranò, Dario Guido Di Febbraro

|Aug 21, 2024
KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.

Sara Santagata, Anna Maria Trotta, Crescenzo D'Alterio

|Nov 11, 2022
CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients.

Crescenzo D'Alterio, Alessandro Giardino, Giosuè Scognamiglio

Pageof 1